Infectious Disease Clinical Trial
Official title:
Adherence to Anti-infectious Treatment Protocols in Emergencies and Short-term Hospitalization at the Infectious Disease Department"
Consensual antibiotic protocols have been developed and validated locally by infectious
disease specialists, internists and emergency physicians, in order to encourage their
compliance. A preliminary study was conducted from June 2015 to February 2016, including 622
patients admitted to the emergency department for infectious syndrome such as /
- Pneumoniae
- Urinary tract infection
- Cellulitis
- Meningitis
- Malaria
- Febrile neutropenia
- Febrile acute diarrhea
- Fever back to the tropics
- Angina
- sexually transmitted infection This prospective study will observe and analyze the
adherence of prescribers to these protocols. With description of patients who benefited
or not the antibiotic protocol, according to a syndromic approach and analysis of the
causes of non-adherence to the protocols. In order to limit the length of stay and
reduce the cost of hospitalization..
Status | Not yet recruiting |
Enrollment | 2000 |
Est. completion date | January 2022 |
Est. primary completion date | July 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patient admitted to emergency for infectious syndrome - Patient > 18 years old. - Patient who accept to have his medical records reviewed for research. Exclusion Criteria: - Patient < 18 years old. |
Country | Name | City | State |
---|---|---|---|
France | Assistance Publique Des Hopitaux de Marseille | Marseille | Paca |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique Hopitaux De Marseille |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | List of Antibiotic treatment | Description of the prescribed antibiotic treatment depending of infectious syndrome: name, duration for each treatment during hospitalization Data will be collected in the medical files: date of introduction of antibiotic treatment withdrawal dates stop dates antibiotic classes |
up to 12 weeks | |
Primary | Adverse events | Description of the cause of non adherence to antibiotic treatment initiates at hospital admission of antibiotherapy: Data will be collected in the medical files of patients: events leading to withdrawal or stop treatment (insufficiency renal, allergic reaction ... etc) date of events aggravation or recovery |
up to 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05568953 -
An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity
|
Phase 2 | |
Completed |
NCT04568889 -
Minnesota COVID-19 Testing Project
|
N/A | |
Completed |
NCT06063330 -
Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects
|
Phase 1 | |
Completed |
NCT01198925 -
Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion
|
Phase 4 | |
Completed |
NCT05063812 -
Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19
|
||
Completed |
NCT03457688 -
Effect of Prebiotic Fructans to Reduce Number of Febrile Infections in Children
|
N/A | |
Completed |
NCT03241355 -
Prebiotic Fructans on the Incidence of Acute Infectious Diseases in Children
|
N/A | |
Terminated |
NCT05420077 -
Safety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273
|
Phase 1 | |
Completed |
NCT04084106 -
Effects of Phenoximethylpenicillin, Amoxicillin and Amoxicillin-clavulanic Acid on the Gut Microbiota
|
Phase 4 | |
Recruiting |
NCT05013944 -
AnovaOS Network Powered Patient Registry
|
||
Completed |
NCT03893279 -
Perception of Smell and Taste During Antibiotic Treatment
|
||
Active, not recruiting |
NCT05619770 -
Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects
|
Phase 1 | |
Completed |
NCT01772901 -
Brief Influenza Vaccine Education to Pregnant Women
|
N/A | |
Completed |
NCT05413772 -
Temocillin in ESBL-Enterobacteriaceae Infections
|
||
Completed |
NCT04319328 -
Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?
|
||
Completed |
NCT04613271 -
Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia
|
Phase 3 | |
Completed |
NCT03239665 -
Vaccination Education Through Pharmacists and Senior Centers (VEPSC)
|
N/A | |
Completed |
NCT03224026 -
Validation of a Proteomic Signature and Assessment of Viremia in Children With Fever Without Source
|
||
Not yet recruiting |
NCT06102070 -
Genetic Susceptibility to Severe Infections
|
||
Recruiting |
NCT04339179 -
Observational Research on Infectious Disease Outbreaks and Difficult Cases of Unidentified Etiology in Indonesia
|